药品注册申请号:089910
申请类型:ANDA (仿制药申请)
申请人:CMP PHARMA INC
申请人全名:CMP PHARMA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL 454GM/BOT No No AA 1989/01/19 1989/01/19 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/01/29 SUPPL-9(补充) Approval Labeling STANDARD
2012/09/25 SUPPL-8(补充) Approval Labeling STANDARD
2000/10/31 SUPPL-5(补充) Approval Manufacturing (CMC)
1992/11/04 SUPPL-4(补充) Approval Labeling
1991/12/04 SUPPL-3(补充) Approval Manufacturing (CMC)
1989/01/19 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:SODIUM POLYSTYRENE SULFONATE 剂型/给药途径:POWDER;ORAL, RECTAL 规格:454GM/BOT 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
089910 001 ANDA SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL 454GM/BOT Prescription No No AA 1989/01/19 CMP PHARMA INC
040029 001 ANDA KIONEX SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL 454GM/BOT Prescription No No AA 1998/02/06 ANI PHARMS
040905 001 ANDA KALEXATE SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL 454GM/BOT Prescription No Yes AA 2009/03/30 KVK TECH
204071 001 ANDA SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL 454GM/BOT Prescription No No AA 2014/11/28 NUVO PHARMS INC
206815 001 ANDA SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL 454GM/BOT Prescription No No AA 2016/02/18 CHARTWELL RX
205727 001 ANDA SODIUM POLYSTYRENE SULFONATE SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL 454GM/BOT Prescription No No AA 2016/02/23 BELCHER
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database